GlaxoSmithKline plc (GSKN) - Total Liabilities

Latest as of September 2025: MX$45.59 Billion MXN ≈ $2.62 Billion USD

Based on the latest financial reports, GlaxoSmithKline plc (GSKN) has total liabilities worth MX$45.59 Billion MXN (≈ $2.62 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore GlaxoSmithKline plc strategic investment ratio to see how much of total assets are deployed in long-term investments.

GlaxoSmithKline plc - Total Liabilities Trend (2013–2024)

This chart illustrates how GlaxoSmithKline plc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see GlaxoSmithKline plc asset portfolio.

GlaxoSmithKline plc Competitors by Total Liabilities

The table below lists competitors of GlaxoSmithKline plc ranked by their total liabilities.

Company	Country	Total Liabilities
GSK PLC SP. ADR/2 NEW F:GS70	Germany	€44.56 Billion
China Yangtze Power Co Ltd SHG:600900	China	CN¥322.17 Billion
Air Liquide SA PA:AI	France	€24.97 Billion
CVS Health Corp NYSE:CVS	USA	$185.68 Billion
Equinix Inc NASDAQ:EQIX	USA	$26.70 Billion
Spotify Technology SA NYSE:SPOT	USA	$5.36 Billion
Sanofi MX:SNYN	Mexico	MX$59.49 Billion
CME Group Inc NASDAQ:CME	USA	$175.38 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down GlaxoSmithKline plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is GlaxoSmithKline plc's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.84	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.82	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GlaxoSmithKline plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GlaxoSmithKline plc (2013–2024)

The table below shows the annual total liabilities of GlaxoSmithKline plc from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	MX$46.38 Billion ≈ $2.67 Billion	+0.36%
2023-12-31	MX$46.21 Billion ≈ $2.66 Billion	-7.67%
2022-12-31	MX$50.05 Billion ≈ $2.88 Billion	-13.35%
2021-12-31	MX$57.76 Billion ≈ $3.32 Billion	-3.12%
2020-12-31	MX$59.62 Billion ≈ $3.43 Billion	-2.79%
2019-12-31	MX$61.34 Billion ≈ $3.53 Billion	+12.76%
2018-12-31	MX$54.39 Billion ≈ $3.13 Billion	+2.84%
2017-12-31	MX$52.89 Billion ≈ $3.04 Billion	-2.27%
2016-12-31	MX$54.12 Billion ≈ $3.11 Billion	+21.43%
2015-12-31	MX$44.57 Billion ≈ $2.56 Billion	+24.79%
2014-12-31	MX$35.72 Billion ≈ $2.06 Billion	+4.20%
2013-12-31	MX$34.27 Billion ≈ $1.97 Billion	--

About GlaxoSmithKline plc

MX:GSKN Mexico Drug Manufacturers - General

Market Cap

$100.93 Billion

MX$1.75 Trillion MXN

Market Cap Rank

#254 Global

#8 in Mexico

Share Price

MX$874.00

Change (1 day)

+1.16%

52-Week Range

MX$801.00 - MX$1041.90

All Time High

MX$1096.34